Neuberger Berman Group LLC Roivant Sciences Ltd. Transaction History
Neuberger Berman Group LLC
- $124 Billion
- Q2 2025
A detailed history of Neuberger Berman Group LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Neuberger Berman Group LLC holds 43,705 shares of ROIV stock, worth $855,743. This represents 0.0% of its overall portfolio holdings.
Number of Shares
43,705
Previous 43,705
-0.0%
Holding current value
$855,743
Previous $492,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding ROIV
# of Institutions
364Shares Held
455MCall Options Held
8.36MPut Options Held
760K-
Sb Investment Advisers (Uk) LTD London, X060MShares$1.17 Billion5.36% of portfolio
-
Morgan Stanley New York, NY44.7MShares$875 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.3MShares$770 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$693 Million0.01% of portfolio
-
Viking Global Investors LP34.2MShares$670 Million1.22% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $13.8B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...